Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V.
Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →
| Cuenta de resultados | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos totales | €17.7B | €17.8B | €18.0B | €18.2B | €17.8B | €17.2B | €17.3B | €17.1B | €18.1B | €17.8B | €24.5B | €24.2B | €21.4B | €23.3B | €24.8B | €22.6B | €25.4B | €23.2B | €26.4B | €26.8B | €27.0B |
| Beneficio bruto | €8.1B | €8.1B | €7.8B | €7.4B | €7.2B | €7.2B | €7.9B | €7.9B | €8.6B | €8.2B | €10.6B | €9.9B | €8.2B | €9.7B | €9.4B | €8.6B | €9.5B | €8.1B | €8.5B | €9.2B | €8.3B |
| % de margen bruto | 45.9% | 45.2% | 43.1% | 41.0% | 40.4% | 41.8% | 45.7% | 46.4% | 47.2% | 46.0% | 43.3% | 40.6% | 38.4% | 41.5% | 38.0% | 38.3% | 37.5% | 34.8% | 32.1% | 34.2% | 30.8% |
| Ingresos operativos (EBIT) | €1.7B | €1.4B | €529M | (€115M) | (€1.5B) | €553M | €1.3B | €1.4B | €1.7B | €1.5B | €1.9B | €992M | €486M | €2.0B | €1.0B | (€269M) | €2.1B | €614M | €54M | €1.9B | €1.2B |
| % de margen operativo | 9.7% | 8.0% | 2.9% | -0.6% | -8.6% | 3.2% | 7.3% | 8.0% | 9.5% | 8.5% | 7.7% | 4.1% | 2.3% | 8.5% | 4.2% | -1.2% | 8.1% | 2.6% | 0.2% | 6.9% | 4.4% |
| Ingresos netos | €1.1B | €895M | (€702M) | (€466M) | (€1.6B) | €3.3B | €1.2B | €1.2B | €1.1B | €1.7B | €1.4B | €645M | €415M | €1.2B | €226M | (€1.3B) | €1.4B | €410M | (€92M) | €4.2B | €5.4B |
| % de margen neto | 6.3% | 5.0% | -3.9% | -2.6% | -9.0% | 19.4% | 6.9% | 6.8% | 6.0% | 9.3% | 5.9% | 2.7% | 1.9% | 5.0% | 0.9% | -5.7% | 5.7% | 1.8% | -0.4% | 15.6% | 20.0% |
| EBITDA | — | €2.6B | €1.8B | €1.0B | €115M | €2.0B | €2.8B | €2.6B | €2.8B | €2.6B | €2.4B | €1.8B | €1.8B | €3.1B | €1.9B | €1.0B | €3.6B | €2.3B | €656M | €2.7B | €2.0B |
| Beneficio por acción (EPS) | €1.16 | €0.93 | €-0.75 | €-0.49 | €-1.69 | €3.49 | €1.24 | €1.20 | €1.09 | €1.64 | €1.46 | €0.66 | €0.42 | €1.19 | €0.23 | €-1.27 | €1.43 | €0.41 | €-0.09 | €3.57 | €4.27 |
| Acciones en circulación (M) | — | 963M | 933M | 949M | 952M | 950M | 958M | 973M | 997M | 1,007M | 990M | 984M | 983M | 983M | 988M | 1,020M | 1,010M | 990M | 1,062M | 1,170M | 1,261M |
Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.
Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de PHG. /companies/us/PHG
La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.
About TickerBase · Data methodology & sources · Privacy · Terms